PerkinElmer adjusts Q1 2020 revenue down

LabPulse.com staff writers
Mar 9, 2020
2019 08 27 23 28 6391 Graph Bar Down 400

PerkinElmer announced that it anticipates its first quarter 2020 revenue to be lower than previously expected.

The adjustment comes after decreased demand in China due to the extension of the Lunar New Year holiday and commercial disruptions due to COVID-19, the company said.

"While we have yet to see significant disruption outside of China, we are keenly monitoring the recent virus-related developments across the globe, as increased transmission rates globally could further impact our current and future financial performance," Prahlad Singh, president and CEO, said in a statement.

Latest in Diagnostic Technologies
Business Regulation Graphic Social Resized
Eurobio Scientific obtains IVDR CE markings for PCR tests
May 24, 2023
Sequencing Dna Rna Social
Illumina CEO remains on the board, chairman is voted out
May 26, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
Money Bag Grant Award Social
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
May 24, 2023
Related Stories
2022 02 02 22 58 0725 Graph Market Down 400
Infectious
PerkinElmer's diagnostics revenue, income dip in Q4
2020 06 17 20 35 0417 Covid 19 Antibody 400
Emergency Use Authorization
PerkinElmer debuts dried blood spot-based COVID-19 serology test
2019 12 03 21 13 6201 Home Magnifying Glass 400
Molecular Diagnostics
PerkinElmer says it's not target of federal probe
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Diagnostic Technologies
Eurobio Scientific obtains IVDR CE markings for PCR tests
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
Business Regulation Graphic Social Resized
Illumina CEO remains on the board, chairman is voted out
Activist investor Carl Icahn, in a proxy fight, had urged the shareholders to remove the chairman and CEO from the board.
May 26, 2023
Sequencing Dna Rna Social
Agilent Technologies fiscal Q2 revenues rise 7%; firm trims full-year estimates
Diagnostics and Genomics Group revenues were $362 million, up 1% year-over-year compared to $358 million.
May 24, 2023
Dna Genome Gene Targeted Social
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
The award, granted as part of the NIH Rapid Acceleration of Diagnostics (RADx) Tech program, will support accelerated validation and scaling of a testing platform to prepare it for a clinical trial.
May 24, 2023
Money Bag Grant Award Social
BPGbio expands agreement with DoD on AI-guided breast cancer diagnostic panel
The diagnostic panel was developed using artificial intelligence to identify patients diagnosed with ER+ breast cancer who do not respond to hormone therapy, to guide caregivers to appropriate treatment options.
May 24, 2023
Breast Mammo Social
Validation data presented for Cytovale sepsis diagnostic test
The lead investigator has presented the results of a study to validate a rapid diagnostic test that detects sepsis in the emergency department. The study data were used to obtain FDA clearance for the test last December.
May 24, 2023
Diagnose Sepsis Social
T2 Biosystems submits FDA 510(k) premarket notification for biothreat panel
The panel is a fully-automated, direct-from-blood test designed to run on the T2 Biosystem’s FDA-cleared T2Dx Instrument and simultaneously detects six pathogens identified as threats by the CDC.
May 23, 2023
Fda Button Social
Antibody titer levels associated with protection against Omicron: Study
Immunoglobin G and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease.
May 23, 2023
Covid 19 Antibody Social
Beckman Coulter analyzer developed 'from the ground up' to address IVD industry constraints
At a time of scarce resources, the system requires no daily maintenance and only 10 minutes weekly and monthly maintenance, said Dr. Pamela Christudoss of Christian Medical College, who evaluated the analyzer prior to its broad launch last week.
May 23, 2023
Dx I 9000 Analyzer Sample Rack Social
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.
May 23, 2023
Artificial Intelligence Ai Social
Biomarkers may predict stem cell transplant risks
A biomarker for donor stem cell transplant risk may help doctors predict which patients will develop potentially deadly sinusoidal obstruction syndrome.
May 23, 2023
Stem Cell 3 D Social
Lifespin debuts diagnostic service, an amino acid profiling panel
Analysis of the samples will be implemented by Lifespin at its sites in Germany and the U.S., and delivered to laboratory chain companies and healthcare providers as software-as-a-service.
May 22, 2023
Laboratory Software Social
Page 1 of 285
Next Page